Page 1 | Search Results | Blood | American Society of Hematology

1-5 of 5

Sort by

Sort Order Select

Journal Articles

The in Vitro and In Vivo Effects of DPP-4 Inhibition with Sitagliptin, Alone and in Combination with Bortezomib, on T Cell Activation: Rationale for GvHD Prevention

Shuhong Zhang, Xingkui Xue, Maggie Granatir, George E. Sandusky, Sheng Liu, Jun Wan, Xiaoling Xuei, Yunlong Liu, Anthony L. Sinn, Karen E. Pollok, Sherif S Farag

Blood (2022) 140 (Supplement 1): 10204–10205.

https://doi.org/10.1182/blood-2022-163679

Published: 2022

Journal Articles

The neurotransmitter receptor Gabbr1 regulates proliferation and function of hematopoietic stem and progenitor cells

Lijian Shao, Adedamola Elujoba-Bridenstine, Katherine E. Zink, Laura M. Sanchez, Brian J. Cox, Karen E. Pollok, Anthony L. Sinn, Barbara J. Bailey, Emily C. Sims, Scott H. Cooper, Hal E. Broxmeyer, Kostandin V. Pajcini, Owen J. Tamplin

Blood (2021) 137 (6): 775–787.

https://doi.org/10.1182/blood.2019004415

Published: 2021

Includes: Supplemental data

Journal Articles

The Novel Aurora Kinase Inhibitor ENMD-2076 Has Potent Single Agent Activity against Multiple Myeloma (MM) in Vitro and in Vivo , and Shows Synergistic Activity in Combination with Lenalidomide

Xiaojing Wang, PhD, Anthony L. Sinn, Attaya Suvannasankha, MD, Colin D. Crean, Li Chen, MD, Shuhong Zhang, PhD, Jing Liang, MD, Genglin Zhang, Karen E. Pollok, PhD, Rafat Abonour, MD, Carolyn Sidor, MD, Mark R. Bray, PhD, Sherif S. Farag, MD, PhD

Blood (2008) 112 (11): 3660.

https://doi.org/10.1182/blood.V112.11.3660.3660

Published: 2008

Journal Articles

Dimethylaminoparthenolide (DMAPT) in Multiple Myeloma

Colin D. Crean, Genglin Zhang, Karen E. Pollok, PhD, Anthony L. Sinn, Peter A Crooks, PhD, Sherif Farag, MBBS, PhD, Rafat Abonour, Attaya Suvannasankha, MD

Blood (2008) 112 (11): 3672.

https://doi.org/10.1182/blood.V112.11.3672.3672

Published: 2008

Journal Articles

Impaired Engraftment of Lineage-Depleted Marrow Cultured for Ex Vivo Gene Transfer in Submyeloablated Murine Hosts.

Brandon K. Wyss, Justin L. Meyers, BA, Anthony L. Sinn, BS, Shanbao Cai, MD, PhD, Karen E. Pollok, PhD, W. Scott Goebel, MD, PhD

Blood (2005) 106 (11): 5545.

https://doi.org/10.1182/blood.V106.11.5545.5545

Published: 2005

NARROW

The in Vitro and In Vivo Effects of DPP-4 Inhibition with Sitagliptin, Alone and in Combination with Bortezomib, on T Cell Activation: Rationale for GvHD Prevention

The neurotransmitter receptor Gabbr1 regulates proliferation and function of hematopoietic stem and progenitor cells

The Novel Aurora Kinase Inhibitor ENMD-2076 Has Potent Single Agent Activity against Multiple Myeloma (MM) in Vitro and in Vivo , and Shows Synergistic Activity in Combination with Lenalidomide

Dimethylaminoparthenolide (DMAPT) in Multiple Myeloma

Impaired Engraftment of Lineage-Depleted Marrow Cultured for Ex Vivo Gene Transfer in Submyeloablated Murine Hosts.

Email alerts

ASH Publications

American Society of Hematology

The in Vitro and In Vivo Effects of DPP-4 Inhibition with Sitagliptin, Alone and in Combination with Bortezomib, on T Cell Activation: Rationale for GvHD Prevention

The neurotransmitter receptor Gabbr1 regulates proliferation and function of hematopoietic stem and progenitor cells

The Novel Aurora Kinase Inhibitor ENMD-2076 Has Potent Single Agent Activity against Multiple Myeloma (MM) in Vitro and in Vivo , and Shows Synergistic Activity in Combination with Lenalidomide

Dimethylaminoparthenolide (DMAPT) in Multiple Myeloma

Impaired Engraftment of Lineage-Depleted Marrow Cultured for Ex Vivo Gene Transfer in Submyeloablated Murine Hosts.

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only